Viatris Inc
NASDAQ:VTRS
Viatris Inc
Long-Term Investments
Viatris Inc
Long-Term Investments Peer Comparison
Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Viatris Inc
NASDAQ:VTRS
|
Long-Term Investments
$165.7m
|
CAGR 3-Years
70%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Long-Term Investments
$4.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Long-Term Investments
$2.2B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-5%
|
|
Pfizer Inc
NYSE:PFE
|
Long-Term Investments
$11.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
32%
|
CAGR 10-Years
-3%
|
|
Merck & Co Inc
NYSE:MRK
|
Long-Term Investments
$1.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-18%
|
|
Eli Lilly and Co
NYSE:LLY
|
Long-Term Investments
$3.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-8%
|
See Also
What is Viatris Inc's Long-Term Investments?
Long-Term Investments
165.7m
USD
Based on the financial report for Mar 31, 2024, Viatris Inc's Long-Term Investments amounts to 165.7m USD.
What is Viatris Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
5%
The average annual Long-Term Investments growth rates for Viatris Inc have been 70% over the past three years , 5% over the past five years .